Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizing Onset Limit and Surgical Outcome Factors in Type II Focal Cortical Dysplasia-Related Epilepsy.

Neurology. Clinical practice·2026
Same author

"Doing Our Best:" A Qualitative Study of Researcher Challenges Administering Neuromodulation Across Different Phenotypes.

AJOB neuroscience·2026
Same author

Thalamo-Lesional Connectivity Signatures of Bilateral Tonic-Clonic Seizures in Focal Cortical Dysplasia-Related Epilepsy.

Annals of clinical and translational neurology·2026
Same author

Personalized Network-Guided Neuromodulation Enhances Human Working Memory.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Active and passive data collection using mHealth to monitor mental wellness: Pilot findings from the Texas resilience against depression study.

Digital health·2026
Same author

Skin-attached bioadhesive patch enabling ultrasound deep brain stimulation and real-time electrophysiological monitoring for REM sleep enhancement.

Nature communications·2026

Related Experiment Videos

Generalizable structure-function covariation predictive of antidepressant response revealed by target-oriented

Xiaoyu Tong1, Kanhao Zhao1, Gregory A Fonzo2

  • 1Department of Bioengineering, Lehigh University, Bethlehem, PA, USA.

Nature. Mental Health
|July 16, 2026
PubMed
Summary

A new machine learning model predicts antidepressant response in major depressive disorder (MDD) by analyzing brain connectivity. This approach offers insights into treatment heterogeneity and aids in developing personalized therapies for MDD.

Related Experiment Videos

Area of Science:

  • Neuroscience
  • Psychiatry
  • Machine Learning

Background:

  • Major depressive disorder (MDD) affects many individuals, but current treatments have limited effectiveness due to poorly understood mechanisms and patient heterogeneity.
  • Developing novel, effective therapies for MDD is crucial, yet progress is hindered by the complexity of the disorder and individual response variations.

Purpose of the Study:

  • To develop a novel machine learning framework for predicting individual antidepressant response in MDD.
  • To identify structure-function covariation patterns in brain connectivity associated with treatment outcomes.
  • To explore the generalizability of predictive biomarkers across different selective serotonin reuptake inhibitors (SSRIs).

Main Methods:

  • A machine learning framework was developed to fuse structural and functional brain connectivity data.
  • The framework was trained to predict individual-level antidepressant response to sertraline and placebo.
  • Model generalizability was validated in an independent cohort of MDD patients treated with escitalopram.

Main Results:

  • The machine learning framework robustly predicted individual antidepressant response (sertraline R 2 = 0.31; placebo R 2 = 0.22).
  • Biomarker generalizability was confirmed in an independent escitalopram-treated cohort (P = 0.01), suggesting shared psychopharmacological signatures across SSRIs.
  • Key brain regions (right precuneus, middle frontal gyrus, fusiform gyrus, inferior frontal gyrus) and network constellations (default-mode regulatory, affective, sensory processing) were identified as predictive of treatment response.

Conclusions:

  • The study presents a novel machine learning approach for predicting antidepressant response in MDD based on brain connectivity.
  • Findings highlight the role of structure-function covariation in MDD heterogeneity and antidepressant response.
  • This framework has the potential to advance precision medicine for MDD by enabling the development of targeted antidepressant therapies.